A Multimodal Dataset for Survival Prediction in Resected Pancreatic Ductal Adenocarcinoma

arXiv:2609.29726 · cs.CV · Submitted 2026-09-24 · Read on arXiv

cs.CV

Submitted: 2026-09-24

Updated: 2026-09-24

License: http://creativecommons.org/licenses/by/4.0/

The gist: Survival research in pancreatic ductal adenocarcinoma (PDAC) is limited by the scarcity of datasets linking whole-slide histology with clinical, molecular, and long-term outcome data.

Terminology

Abstract

Survival research in pancreatic ductal adenocarcinoma (PDAC) is limited by the scarcity of datasets linking whole-slide histology with clinical, molecular, and long-term outcome data. We present a retrospective single-centre cohort of 302 patients who underwent PDAC resection at University Medical Center Gottingen. The dataset comprises 446 H&E whole-slide images, clinicopathological variables, targeted sequencing data for 154 patients, and overall-survival outcomes. During follow-up, 253 patients died, and the median follow-up was 76 months. To establish initial reference values, we evaluated fourteen survival-prediction configurations using identical five-repetition Monte Carlo cross-validation partitions. Ridge Cox regression using numeric clinicopathological variables achieved a mean concordance of 0.649 plus or minus 0.042 and 0.652 plus or minus 0.046 after adding KRAS and TP53 mutation status. The image-only attention model achieved 0.603 plus or minus 0.030, while multimodal fusion achieved 0.619 plus or minus 0.025, the highest concordance among the neural models. These results establish promising initial benchmarks for future research using this pancreas-specific multimodal dataset, paving the way for external validation.

Sources

Related papers